Before joining Azelis, Evy spent two years in the medical devices division of Johnson & Johnson
Azelis Group announces the appointment of Evy Hellinckx to succeed Anna Bertona as CEO of Azelis EMEA when Anna assumes her new role as Group CEO on Jan 1, 2024.
Evy has held strategic leadership roles within Azelis since 2016. In her current role as Managing Director of Azelis Benelux, she has grown the company’s footprint significantly in the region over the past two years. Prior to her Benelux role, Evy was Strategy and Business Development Director for EMEA, where she was responsible for principal management across all segments in the region, and was instrumental in realizing some of the largest multi-country mandate gains in the region.
As part of the EMEA leadership team, Evy has contributed to the development and implementation of key strategic programs in the region. In addition, she was tapped to provide support to the Group Executive Committee in developing the Azelis 2017-2023 strategy.
Before joining Azelis, Evy spent two years in the medical devices division of Johnson & Johnson, and ten years in strategic consulting at Bain & Company. She holds a master’s degree in Commercial Engineering from the Catholic University of Leuven in Belgium.
Register Now to Attend ChemConnect 2023 on Friday, 13th October 2023, Mumbai
Subscribe To Our Newsletter & Stay Updated